Thermic and tremorogenic effects of thyroliberin (TRH) in reserpine-treated mice--the non-involvement of GABA-ergic mechanisms

J Pharm Pharmacol. 1981 Sep;33(9):580-5. doi: 10.1111/j.2042-7158.1981.tb13870.x.

Abstract

Administration of thyroliberin (TRH) to reserpinized mice causes tremor and counteracts the hypothermia in a dose-dependent fashion. The thyroliberin response is inhibited by gamma-hydroxybutyric acid (GHB) and baclofen, but not by other, more specific GABA-ergic agents, such as THIP, gamma-acetylenic GABA, and sodium valproate. Picrotoxin neither potentiates nor inhibits the thyroliberin actions. Nor are the thyroliberin effects dependent on cholinergic, monoaminergic or histaminergic mechanisms. The results repudiate a current hypothesis, that the peptide actions may be mediated by GABA-ergic pathways in the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Baclofen / pharmacology
  • Body Temperature Regulation / drug effects*
  • Dose-Response Relationship, Drug
  • Hydroxybutyrates / pharmacology
  • Male
  • Mice
  • Mice, Inbred Strains
  • Receptors, Cell Surface / drug effects*
  • Receptors, GABA-A
  • Reserpine / pharmacology*
  • Sodium Oxybate
  • Thyrotropin-Releasing Hormone / pharmacology*
  • Tremor / chemically induced*

Substances

  • Hydroxybutyrates
  • Receptors, Cell Surface
  • Receptors, GABA-A
  • Thyrotropin-Releasing Hormone
  • Sodium Oxybate
  • Reserpine
  • Baclofen